Fact Check: Does Paracetamol consumption during pregnancy leads to autism in newborn children?

The recent announcement by US President Donald Trump’s in a video has created shockwaves claim that using acetaminophen (Tylenol/Paracetamol) during pregnancy may cause autism.  While this statement appears alongside recent FDA statement on label change on acetaminophen, the claim itself is misleading and exaggerated. Current scientific evidence does not establish a direct causal link, and presenting it as such risks spreading unnecessary fear among the public.

Claim

In a recent video, US President Donald Trump said that pregnant women should not take paracetamol. He goes on to add it should also not be given to children.

In the video he says, “First, effective immediately, the FDA will be notifying physicians at the use of well, let’s see how we say that. Acetaminophen. Acetaminophen. Is that okay?

which is basically commonly known as Tylenol during pregnancy can be associated with a very increased risk of autism. So taking Tylenol is uh not good. All right, I’ll say it. It’s not good.

For this reason, they are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary. That’s for instance in cases of extremely high fever. That you feel you can’t tough it out, you can’t do it. I guess there’s that. It’s a small number of cases, I think. But if you can’t tough it out, if you can’t do it, that’s what you’re going to have to do.

You’ll take a tylenol, but it’ll be very sparingly. Can be something that’s very dangerous to the woman’s health. In other words, a fever that’s very very dangerous and ideally a doctor’s decision because I think you shouldn’t take it and you shouldn’t take it during the entire pregnancy. They may tell you that toward the end of the pregnancy, you shouldn’t take it during the entire and you shouldn’t give the child a Tylenol every time he goes. He’s born and he goes and has a shot.

You shouldn’t give a Tylenol to that child. All pregnant women should talk to their doctors for more more information about limiting the use of this medication while pregnant. So ideally, you don’t take it at all, but if you have to if you can’t tough it out or if there’s a problem, you’re going to end up doing it. The other thing that I can tell you that I’ll say that they will maybe say at a little bit later date. But I think when you go for the shot, you do it over a five-time period.”

The video can be accessed here and Here

Fact Check

The claim by the user is MISLEADING, as current scientific evidence remains inconclusive and does not confirm any direct causal relationship between consumption of paracetamol in pregnancy and autism in chidlren . While the FDA has issued guidance on cautious use it also itself specifies about the documented side effects of other options such as aspirin and ibuprofen adding that that acetaminophen is the only over-the-counter drug approved for use to treat fevers during pregnancy.

The claims made in the US President’s speech exaggerate the risk misrepresenting the actual scientific consensus and may lead to public confusion.

What is Pregnancy?

Pregnancy is the stage when a fetus grows inside a woman’s uterus, lasting about 40 weeks and divided into three trimesters. It begins with conception, when a sperm fertilizes an egg, creating a zygote that attaches to the uterine lining. During the second trimester (weeks 13–28), fetal movements are typically felt by week 20, and by week 24, unique fingerprints have formed. By week 28, premature babies have a 92% chance of survival, though health risks remain. In the third trimester (weeks 29–40), the baby’s bones are nearly developed by week 32, and infants born at full term (weeks 39–40) generally experience the best health outcomes. Babies born between weeks 37–38 are classified as “early term,” while those delivered after week 42 are considered “post-term.”

What is Autism?

Autism, also known as autism spectrum disorder (ASD), encompasses a wide variety of conditions that involve difficulties with social interaction, repetitive patterns of behavior, as well as challenges in speech and nonverbal communication. The Centers for Disease Control and Prevention (CDC) estimates that autism currently affects about 1 in 36 children and 1 in 45 adults in the United States.

The experiences and capabilities of individuals with autism differ greatly. While some are able to live independently, others may need lifelong care and support. Autism can have a substantial impact on access to education and employment, and it often places significant responsibilities on families and caregivers. Quality of life is also shaped by societal perceptions and the degree of assistance provided by both local and national systems.

According to the World Health Organization (WHO), many people with autism experience additional conditions such as epilepsy, depression, anxiety, and attention deficit hyperactivity disorder. They may also exhibit challenging behaviors, including sleep difficulties and self-injury. Intellectual abilities within the autistic community vary widely, ranging from profound disability to exceptional levels of functioning.

What is Acetaminophen (Tylenol/Paracetamol)?

Paracetamol ( also known as Acetaminophen and sold under brand name Tylenol in US) is a widely used analgesic and antipyretic medication for relieving pain and reducing fever. After oral or intravenous administration, it acts quickly (within 30–60 minutes orally; 5–10 minutes IV) and lasts for about 4–6 hours. It is metabolized in the liver and rarely excreted unchanged. Common side effects include nausea, vomiting, and rectal irritation. It is available in multiple forms, including tablets, capsules, syrups, suspensions, elixirs, and injections.

Does Acetaminophen (Tylenol/Paracetamol) use during pregnancy cause Autism?

Donald Trump claimed in a video that pregnancy women should not take acetaminophen (Tylenol/Paracetamol) during pregnancy. This statement is misleading and exaggerates the association between acetaminophen or paracetamol consumption during pregnancy and autism in children. There are indeed some studies that have suggested a possible link between prenatal acetaminophen use and attention-related issues in children, there is no strong or conclusive evidence that it causes autism. 

A consensus statement in Nature Reviews Endocrinology warns that while paracetamol (acetaminophen) is widely considered safe in pregnancy, emerging evidence links prenatal use to risks such as autism, ADHD, and other developmental disorders. Experts recommend using it only when necessary, in the lowest effective dose, and for the shortest time.

The FDA has issued a notice to physicians regarding acetaminophen use during pregnancy, highlighting accumulating evidence that prenatal exposure may be linked to a higher risk of neurological conditions in children, including autism and ADHD.

In contrast, scientific studies show that acetaminophen use during pregnancy is not associated with an increased risk of autism. A study published in JAMA Network by Viktor H. Ahlqvist and colleagues reported that using acetaminophen during pregnancy was not linked to an increased risk of autism, ADHD, or intellectual disability in children.

According to the NHS, paracetamol is considered the preferred pain relief option during pregnancy. It is widely used by expectant mothers and is not harmful to the baby.

A Nature Reviews Endocrinology consensus statement indicates that prenatal paracetamol use could impact fetal development and pose health risks. In response, the American College of Obstetricians and Gynecologists reaffirmed that existing guidance remains the same: acetaminophen need not be avoided but should be used carefully and only when necessary.

On September 24, 2025, following a statement by Trump, the World Health Organization (WHO) clarified that there is no conclusive scientific evidence supporting a link between acetaminophen (paracetamol) use during pregnancy and autism. The statement noted, 

“The World Health Organization (WHO) emphasizes that there is currently no conclusive scientific evidence confirming a possible link between autism and use of acetaminophen (also known as paracetamol) during pregnancy.

Globally, nearly 62 million people (1 in 127) have autism spectrum disorder, a diverse group of conditions related to development of the brain. Although awareness and diagnosis have improved in recent years, the exact causes of autism have not been established, and it is understood there are multiple factors that can be involved.

Extensive research has been undertaken over the past decade, including large-scale studies, looking into links between acetaminophen use during pregnancy and autism. At this time, no consistent association has been established.

WHO recommends that all women continue to follow advice of their doctors or health workers, who can help assess individual circumstances and recommend necessary medicines. Any medicine should be used with caution during pregnancy, especially in the first three months, and in line with advice from health professionals.

Also, a robust, extensive evidence base exists showing childhood vaccines do not cause autism. Large, high-quality  studies from many countries have all reached the same conclusion. Original studies suggesting a link were flawed and have been discredited. Since 1999, independent experts advising WHO have repeatedly confirmed that vaccines—including those with thiomersal or aluminum—do not cause autism or other developmental disorders.  

Childhood vaccine schedules are developed through a careful, extensive and evidence-based process involving global experts and country input. The childhood immunization schedule, carefully guided by WHO, has been adopted by all countries, and has saved at least 154 million lives over the past 50 years. The schedule remains essential for the health and wellbeing of every child and every community. These schedules have continually evolved with science and now safeguard children, adolescents and adults against 30 infectious diseases.

Every vaccine recommendation by the Strategic Advisory Group of Experts on Immunization (SAGE), an independent advisory group to WHO, is grounded in rigorous review of evidence and carefully designed to offer the best protection against serious diseases and to be delivered when most needed.

When immunization schedules are delayed or disrupted, or altered without evidence review, there is a sharp increase in the risk of infection not only for the child, but also for the wider community. Infants too young to be vaccinated and people with weakened immune systems or underlying health conditions are at greatest risk.

Autism and neurodevelopmental disorders are among priority mental health and neurological conditions being discussed at the 4th UN High-Level Meeting on NCDs and mental health this Thursday, 25 September. As a global community, we need to do more to understand the causes of autism and how best to care for and support the needs of autistic people and their families.  

WHO is committed to advancing this goal working together with partners including autistic-led organizations and other organizations representing persons with lived experience. WHO also stands with people who are living with autism and their families, a dignified community entitled to evidence-based considerations free of stigma.”

Therefore, it can be concluded that the claim is misleading.

What do Doctors say?

Dr Pratiksha Gupta, MBBS MD Obstetrics & Genecology, FIMSA in a conversation with The Medical Dialogues Fact Check Team said, “As a gynecologist, I often meet expectant mothers who are anxious about every little thing they consume during pregnancy. 

Paracetamol has been used safely by pregnant women across the world for decades. It is the most trusted medicine for reducing fever and managing mild pain in pregnancy.

So where did the worry come from? A few studies suggested a possible link between paracetamol use in pregnancy and conditions like autism or ADHD. But these studies only showed an association, not a cause. In simpler terms, just because two things happen together doesn’t mean one is responsible for the other. There were many other factors in those studies, including genetics, environment, and the mother’s health, which could have influenced the results.

Trusted health organizations like the American College of Obstetricians and Gynecologists and the FDA continue to recommend paracetamol as the first choice for pain and fever in pregnancy. They are clear that there is no solid scientific proof linking its use to autism. On the other hand, untreated fever during pregnancy can itself be dangerous for both mother and baby, making paracetamol not just safe but necessary in many situations.

If you are pregnant and need to take paracetamol, you can do so without fear. Use it in moderation, only when you need it, and always at the dose your doctor recommends. If you find yourself needing it frequently, it’s a good idea to talk to your doctor to address the underlying problem.

The bottom line is simple: taking paracetamol during pregnancy does not cause autism. It remains a safe and effective medicine for mothers-to-be. So if you have reached for it to ease pain or bring down a fever, you can breathe easy—you have not harmed your baby.”

Dr Pallavi Gupta, Consultant Pediatrician, SK Jain Hospital, Geeta Colony further said, “Acetaminophen (Tylenol/Paracetamol) has been used for decades as one of the safest medications to reduce fever and relieve pain during pregnancy. Some observational studies have suggested a possible link with conditions like autism or ADHD, but these studies only show an association, not proof of cause. Many other factors—such as maternal illness, infections, fever itself, genetics, and environment—can influence outcomes, making it misleading to blame acetaminophen directly.

In fact, untreated high fever in pregnancy carries known risks for both mother and baby. Safely controlling fever is important, and acetaminophen remains the best first-line choice recommended by doctors.

Respected health organizations, including the American College of Obstetricians and Gynecologists (ACOG) and the U.S. Food and Drug Administration (FDA), continue to affirm that acetaminophen is safe when used correctly. Their advice is to use the lowest effective dose for the shortest necessary time, which is a principle for all medications during pregnancy.

Parents should feel reassured that current evidence does not support avoiding acetaminophen out of fear of autism. Sensational claims online can cause unnecessary stress. The safest path is balanced, careful use under medical guidance, not avoidance based on misleading claims.”

Medical Dialogues Final Take

Although some studies have suggested a possible link between prenatal acetaminophen use and attention-related issues in children, there is no conclusive evidence that it causes autism. The FDA has issued guidelines on its use, but the majority of high-quality research confirms no causal connection between acetaminophen in pregnancy and autism. Leading health authorities, including the NHS, ACOG, and WHO, continue to recommend it as a safe option when used as directed, and large-scale studies consistently show no association.

Therefore, the claim is misleading and overstated.

Powered by WPeMatico

Chennai ESIC medical college MBBS students allege seniors forcing them to shift to collapsed hostel building

Chennai- Third-year MBBS students of the ESIC Medical College in KK Nagar, Chennai, have raised concerns about their safety after being allegedly coerced into returning to their partially collapsed hostel building.

According to the DTNext report, it is alleged that the third-year students are being forced by the fourth-year seniors to vacate the temporary space and return to the third floor of the damaged building, where the seniors are currently staying.

Speaking to DTNext about this, a college source said, “The seniors want to stay in the single room where the third-year students are currently staying, which is the interns’ hostel. Thus, the seniors are harassing the juniors to shift during the exams. This is not only causing unnecessary anxiety but also posing a security threat.”

Adding to their fears, students reported that a portion of the ceiling of the third-floor restroom also recently collapsed. The rooms on the fourth floor of the original building, where they previously lived, collapsed in May. Students say that despite repeated requests, the college management has not provided any safety assurances, and no structural safety certificate is available for the old building.

According to a DTNext Media news report, internal sources alleged that despite visible structural damage and persistent safety hazards, management and senior students are insisting that they move back to the old building, where a portion of a room on the fourth floor collapsed in May 2025. Fortunately, no injuries were reported during the incident as the room was empty at the time.

Following the incident, more than 20 third-year students were relocated to a nearby building that only offers single-room accommodation. However, the old building, which is now damaged, had triple-sharing accommodation. Although it remains unrepaired and is visibly damaged, a grim reminder of the risks involved.

Powered by WPeMatico

Rekha Gupta launches organ donation portal

New Delhi: Delhi Chief Minister Rekha Gupta on Thursday launched an online organ donation portal and dedicated 11 new Centralised Accident and Trauma Services (CATS) to the people, promising to induct another 53 such life-saving emergency vehicles in October. 

Addressing a gathering at the launch of the 11 new ambulances, CM Gupta said, “The government is committed to improving medical facilities in the city”.

Pointing to Prime Minister Narendra Modi‘s call to eradicate TB from the country, she said the Delhi government has screened 56,000 people and detected nearly 1,000 TB patients in its first 100 days.

Also Read:AIIMS Delhi hosts women’s health camp; CM Rekha Gupta visits

She said that for modern testing of TB, 40 Truenat machines, 10 PathoDetect machines, and 27 handheld X-ray machines have been provided by the Delhi government.

“A digital portal for organ donation has also been launched, and a new DEIC centre has been started at Nehru Bal Chikitsalaya,” she wrote on X.

“Additionally, 11 new CATS ambulances have also been dedicated to public service. All these initiatives will further strengthen Delhi’s health infrastructure and give every citizen the confidence of better and modern treatment,” she said on X, reports IANS.

“Our government has, for the first time, reached health services to every individual through the permanent appointment of nurses, the establishment of hundreds of Ayushman Arogya Mandirs, the arrangement of state-of-the-art testing machines, and large-scale screening campaigns,” she said.

CM Gupta said the government has also launched a portal on which organ donors will be able to register. “We also plan to create a state body to streamline organ donation. It will be modelled on the Central government’s National Organ and Tissue Transplant Organisation (NOTTO), which is a national-level organisation.”

Delhi government Cabinet Minister Pankaj Kumar Singh was also present at the programme.

The Chief Minister said that the launches on Thursday were part of the 75 schemes and welfare projects to be dedicated to the public during the government’s 15-day ‘Seva Pakhwada’ being observed to celebrate PM Modi’s birthday. The Pakhwada is being observed from September 17 to October 2.

Also Read:Over 1,000 doctors to join Aarogya Mandirs in Delhi

Powered by WPeMatico

Diabetic retinopathy and CKD increased CV risk in diabetes patients: Study

A new study published in the journal of Diabetes Research and Clinical Practice showed that proliferative diabetic retinopathy (PDR) increased cardiovascular risk in more than 2 million people with type 2 diabetes (T2D) in a manner comparable to that of chronic kidney disease (CKD), with risk tripling when both conditions coexisted. 

Because type 2 diabetes is strongly linked to an elevated risk of cardiovascular disease (CVD) and death, it is a significant global public health problem. Controlling cardiovascular disease risk factors is essential since it continues to be the primary cause of mortality for people with type 2 diabetes.

Studies with large populations have repeatedly demonstrated that CKD, a significant microvascular consequence of type 2 diabetes, raises the risk of CVD and death. Although its exact role is still unknown, diabetic retinopathy (DR) has also been found to be a risk factor for CVD in people with type 2 diabetes. The relationship between DR and CVD has been the subject of several meta-analyses.

Microvascular and macrovascular problems in diabetic individuals are influenced by age and sex. Notably, a greater risk of microvascular and macrovascular problems is linked to a younger age at diabetes diagnosis. Using a sizable cohort from the Korean National Health Insurance Service (NHIS), this study sought to assess the separate and combined effects of DR and CKD on the risk of CVD and mortality among people with type 2 diabetes. The data from the UK Biobank cohort was then used for external validation.

This research examined T2D patients without a history of CVD from the UK Biobank (n = 21,350) and the Korean NHIS cohort (n = 2,064,406). A composite of nonfatal myocardial infarction, nonfatal stroke, and cardiovascular mortality was the main result. Adjusted hazard ratios (aHRs) for the primary outcome were higher in the Korean cohort for those with PDR (aHR 1.37), CKD (aHR 1.36), and both conditions combined (aHR 2.21), than in those without either condition.

Comparable outcomes were noted in the UK Biobank. With aHRs of 3.28 for those under 40, 1.77 for those between 40 and 64, and 1.29 for those over 65, PDR had the greatest impact on CVD in younger people. Overall, pDR and CKD, both independently and in combination, increase cardiovascular risk in individuals with T2D, particularly among younger age groups. These findings support incorporating PDR into cardiovascular risk assessment and management.

Reference:

Yeon Soo Park, Kyu Na Lee, Bo Kyung Koo, Soo Heon Kwak, Kyung Do Han, Min Kyong Moon., Diabetic retinopathy and chronic kidney disease synergistically increase the risk of incident cardiovascular disease in type 2 diabetes: Insights from two cohort studies., Diabetes Research and Clinical Practice., https://doi.org/10.1016/j.diabres.2025.112373

Powered by WPeMatico

AYUSH Ministry, WHO to co-host 2nd WHO Global Summit on Traditional Medicine in December

New Delhi: The Ministry of Ayush recently signed an agreement with the World Health Organization (WHO) to co-host the 2nd WHO Global Summit on Traditional Medicine on the theme ”Restoring balance for people and planet: The science and practice of well-being”.

The Summit will be held in New Delhi from 17th to 19th December 2025.

Also Read:AYUSH Ministry to host 2-day National Summit to boost capacity building

The agreement signing took place in the presence of Union Minister of State for Ayush (IC), Shri Prataprao Jadhav, and Secretary, Ministry of Ayush, during the 2nd Summit Planning Group Meeting convened to monitor activities and progress for the upcoming Summit.

The Global Summit will serve as an important international platform bringing together experts, policymakers, and stakeholders to advance the role of traditional medicine in global health and sustainable development.

The Ministry of Ayush, in partnership with WHO, reaffirmed its commitment to fostering evidence-based traditional medicine practices that contribute to human and planetary well-being.

Medical Dialogues had earlier reported that the Ministry of Ayush hosted a Press Conference in Panaji, Goa, on the occasion of the 10th Ayurveda Day to highlight the significance of Ayurveda, its contributions to holistic health, and the special events planned to mark the milestone celebration. Addressing the media, Professor (Vaidya) Pradeep Kumar Prajapati, Director, All India Institute of Ayurveda (AIIA), Goa, said that the theme “Ayurveda for People, Ayurveda for Planet” underscores personal health, global well-being, ecological balance, and sustainable development. He emphasized that the 10th Ayurveda Day is an opportunity to take Ayurveda to every individual and reaffirm its role in global health. 

He also highlighted the inauguration of new healthcare facilities at AIIA Goa, including an Integrated Oncology Unit, Central Sterile Supply Department, Linen Processing Unit, and Blood Bank, which will strengthen the bridge between Ayurveda and modern medicine.

Also Read:AIIA holds bike rally under the theme Ayurveda for People and Planet

Powered by WPeMatico

BFUHS notifies on deadline extension for nursing admissions 2025, details

Punjab– The Baba Farid University of Health Sciences (BFUHS) has informed regarding the extension of the last date of admission for all Nursing Programs for the Academic Year 2025-26.

In continuation to earlier notification, Indian Nursing Council has extended the last date of admission to nursing programs ie. ANM, GNM, B.Sc.(N), PBB.Sc.(N), M.Sc.(N), Ph.D(N), Post Basic Diploma and Nurse Practitioner programs from 30th September 2025 to 31st October 2025, the BFUHS notified.

Medical dialogues had earlier reported that the vacancy position, a total of 106 seats are vacant for MSc Nursing and Post Basic BSc (N) courses. Of these, a total of 54 seats are vacant across MSc Nursing courses in 3 Nursing Colleges and a total of 52 seats are vacant across Post Basic BSc (N) courses in 6 Nursing Colleges. Below are the detailed vacancies-

VACANCY POSITION M.Sc NURSING

S.NO COLLEGE VACANT
SEATS
1 University College of Nursing, Faridkot. 8
2 State Institute of Nursing &
Para–Medical Sciences, Badal.
22
3 Institute of Nursing URC Goindwal Sahib. 24
TOTAL 54

VACANCY POSITION POST BASIC BSc (N)

S.NO COLLEGE VACANT
SEATS
1 University College of Nursing, Faridkot. 10
2 Institute of Nursing URC Goindwal Sahib. 6
3 University Institute of Nursing,
Jalalabad.
25
4 Govt. CON, Rajindra Hospital, Patiala. 5
5 Govt. CON, Amritsar. 3
6 State Institute of Nursing &
Para–Medical Sciences, Badal.
3
TOTAL 52

FEE REQUIRED WITH ADMISSION APPLICATION FORM FOR MSc NURSING

1 Rs 5000/- +18% GST(5900)+ HSLIBNET fee 3000/- for General Category and SC candidates will deposit a fee of Rs 2500+18% GST(Rs 2950/-) + HSLIBNET fee 3000/- to be deposited online, payable at University College of Nursing, Faridkot on the day of form deposition/ submission.

2 The selected candidates have to pay Rs 50000/-(Tution fee) in the shape of Bank Demand Draft in favor of Registrar, Baba Farid University of Health Sciences, payable at Faridkot.

FEE REQUIRED WITH ADMISSION APPLICATION FORM FOR BASIC BSc (N)

1 Rs. 3000/- +18% GST+ Counselling fee Rs. 1000/-(Rs. 4540/-)+ HSLIBNET fee 1500/- for General Category and SC candidates will deposit fee of Rs. 1500+18% GST Rs 1770/- + Counselling fee Rs 1000/-(Rs. 2770/-)+ HSLIBNET fee 1500/- to be deposited online, payable at University College of Nursing, Faridkot, on the day of form deposition/ submission.

2 The selected candidates have to pay Rs. 51000/-( Tution fee) in the shape of Bank Demand Draft in favor of Registrar, Baba Farid University of Health Sciences, payable at Faridkot.

The candidate who has already been selected and has joined the allotted college in the central counselling conducted by the BFUHS, Faridkot, shall participate in the college-level counselling, subject to the condition that he/she produces Original Certificates for shifting at college-level counselling.

To view the official Notice, click here: https://medicaldialogues.in/pdf_upload/date-extend-notice-for-nursing-coruse-session-2025-302291.pdf

Powered by WPeMatico

Severe Alcohol-Associated Hepatitis Still Carries High Short-Term Mortality, Meta-Analysis Finds

USA: Short-term mortality among patients with severe alcohol-associated hepatitis (sAH) remains alarmingly high despite decades of clinical advances, a recent meta-analysis published in Alimentary Pharmacology & Therapeutics has shown.

The analysis, led by Dr. Mushfiqur R. Siddique and colleagues from the Department of Internal Medicine at Jamaica Hospital Medical Center, New York, highlights that survival rates have shown little meaningful improvement over the past 50 years. The authors call for urgent action to develop more effective treatments, refine patient selection for early liver transplantation, and strengthen strategies to prevent this life-threatening condition.
The review pooled data from 34 investigations involving 1,586 patients diagnosed with sAH. By examining mortality at 28, 60, and 90 days after diagnosis, the team sought to chart trends in outcomes over five decades. Advanced statistical approaches—including random-effects meta-regression and Bayesian mixed-effects models—were applied to identify mortality patterns and potential risk factors while accounting for differences across studies.
Key Findings:
  • Pooled mortality estimates were 26.8% at 28 days, 35.1% at 60 days, and 43.7% at 90 days, showing that the risk of death rises steadily during the first three months after presentation.
  • An initial decline in 28-day mortality was observed, dropping from over 50% in the 1970s to about 25% after 2000, but decade-by-decade analysis showed no statistically credible improvement in survival over the last four decades.
  • Considerable heterogeneity existed across the included studies, yet the overall short-term prognosis remained poor.
  • Higher Model for End-Stage Liver Disease (MELD) scores were identified as a significant predictor of mortality in multivariable analyses adjusted for follow-up duration.
  • The findings reinforce the MELD score’s value as an important tool for risk assessment and clinical decision-making in severe alcohol-associated hepatitis.
Dr. Siddique and colleagues stress that the stagnant mortality rates point to a critical gap in available therapies. Current supportive measures, including corticosteroid treatment, have limited effectiveness, and many patients fail to respond. Early referral for liver transplantation may offer a lifeline for select candidates, but identifying who will benefit most remains challenging. The authors also emphasize the need for preventive measures, such as comprehensive programs to curb harmful alcohol use, which could reduce the incidence of this aggressive liver disease.
The extensive review paints a troubling picture: despite medical advances, severe alcohol-associated hepatitis continues to carry a high short-term mortality rate, with little evidence of improvement since the 1970s.
“The findings highlight the urgent necessity for innovative treatments, improved prognostic tools, and public health strategies that address modifiable risk factors to improve survival and reduce the burden of this devastating condition,” the authors concluded.
Reference:
Siddique, M. R., Haque, M., Idalsoaga, F., Diaz, L. A., Im, G., Singal, A. K., Hoang, S., Khan, M. Q., & Arab, J. P. Meta-Analysis: Mortality Trends and Risk Factors in Severe Alcohol-Associated Hepatitis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70383

Powered by WPeMatico

Increased risk of depression and psychosis after childbirth among mothers: Study

Depression and psychosis are more common in women after childbirth than before, but the risk of suicide attempts decreases. This is shown by two new studies from Karolinska Institutet. The results suggest that national guidelines for screening can help women get help earlier.

Mental ill health in connection with pregnancy and childbirth can have long-term consequences for women’s health. During this period, major biological and psychosocial changes occur that can increase vulnerability to depression, anxiety, and other psychiatric conditions. Despite previous research, knowledge has been limited, especially regarding how different psychiatric diagnoses develop before, during, and after pregnancy.

In a new study, researchers have used data from Swedish registers covering all women who gave birth in Sweden between 2003 and 2019 – a total of nearly 1.8 million pregnancies.

The study, published in the journal Molecular Psychiatry, shows that mental ill health has increased over time during this period, especially before pregnancy. During pregnancy itself, the number of new diagnoses decreases, but after childbirth, the risk increases again, especially for depression and psychosis.

“We can see that the risk of depression is about 20 percent higher during weeks 5 to 15 after childbirth, compared to the year before pregnancy. For psychosis, the risk is up to seven times higher during the first 20 weeks after childbirth,” says the study’s first author Emma Bränn, researcher, Institute of Environmental Medicine, Karolinska Institutet.

When national guidelines for screening pregnant women for depression were introduced in 2020, it opened up the possibility of detecting mental illness earlier. By comparing women who gave birth before and after 2020, the researchers saw that the peak of depression diagnoses occurred earlier after childbirth in women who gave birth after the guidelines were introduced.

“We don’t see that more people are being diagnosed, but screening could mean that women are identified earlier and don’t have to suffer as long before they can get the support and help they need,” says Emma Bränn.

The study also shows that the risk of other psychiatric diagnoses, such as anxiety, stress-related conditions, and substance abuse, is lower during pregnancy and after childbirth compared to before. The researchers believe that this may be due to biological changes, lifestyle changes, and increased contact with healthcare during pregnancy.

Another study from the same research group has investigated the risk of suicide in connection with pregnancy and childbirth. In the study, published in Nature Human Behaviour, researchers found that mothers were less likely to attempt suicide during and after pregnancy compared to fathers. This is the opposite of what researchers usually observe in the general population, where women tend to have higher rates of suicide attempts than men. For fathers, the risk decreased in the first ten weeks after childbirth, only to increase again.

“Our results suggest that both mothers and fathers are less likely to attempt suicide immediately after having a child, especially mothers,” says first author Yihui Yang, PhD student at the Institute of Environmental Medicine, Karolinska Institutet. She continues:

“Although suicide attempts during and after pregnancy are rare, they can have devastating consequences and are often preventable. It is therefore important that healthcare providers conduct regular check-ups during and after pregnancy to identify parents who are struggling and offer support to prevent suicide.”

Reference:

Bränn, E., Guintivano, J., Yang, Y. et al. Maternal psychiatric disorders before, during, and after pregnancy: a national cohort study in Sweden. Mol Psychiatry (2025). https://doi.org/10.1038/s41380-025-03212-9

Powered by WPeMatico

Validated nomogram may Predict upper GI bleeding in peritoneal dialysis Patients: Study

Researchers have found in a new study that Calcium and PPI use, history of upper gastrointestinal bleeding (UGIB), hemoglobin levels, and uric acid were identified as significant predictors of UGIB in peritoneal dialysis (PD) patients. Therefore a validated nomogram based on these factors shows promise as a clinical tool for predicting UGIB risk in this population. The study was published in BMC Nephrology by Sijia S. and colleagues.

This retrospective study involved information from 2,107 PD patients who were treated from February 1, 2007, to November 15, 2021. The patients were split into training and validation groups randomly in a 1:1 ratio. Researchers used the least absolute shrinkage and selection operator (LASSO) regression method to determine candidate UGIB predictors. The predictors were then utilized to create a nomogram model.

To test the performance of the nomogram, the accuracy and clinical value of the model were both checked with a variety of metrics, ranging from receiver operating characteristic (ROC) curves and calibration curves to decision curve analysis (DCA). This strict testing guaranteed that the model was not only statistically valid but also useful in practice.

Key Findings

Of the 2,107 patients examined, 114 had UGIB. Five predictors were found to be predictive of UGIB and were included in the nomogram:

  • Calcium supplement use

  • Proton pump inhibitor (PPI) use

  • History of UGIB

  • Hemoglobin

  • Uric acid

  • The nomogram had excellent predictive performance.

  • The C-index, a measure of model discrimination, was 0.859 (95% CI: 0.810–0.909) in the training set and 0.874 (95% CI: 0.829–0.919) in the validation set.

  • These results reflect high accuracy in separating patients at risk for UGIB.

The analysis conclusively demonstrated that the application of calcium and PPIs, history of UGIB, hemoglobin level, and uric acid were the key predictors of UGIB in peritoneal dialysis patients. The reliable nomogram derived from these factors provides a convenient method of estimating the risk of UGIB. It has the potential to be used as a clinical decision-support tool to enhance patient care and outcomes in this high-risk group.

Reference:

Shang, S., Zhang, X., Zhan, X. et al. Development and validation of a predictive model for upper gastrointestinal bleeding in peritoneal dialysis patients: a retrospective, multicenter cohort study. BMC Nephrol 26, 383 (2025). https://doi.org/10.1186/s12882-025-04304-y

Powered by WPeMatico

Predicta Bioactive Bulk as effective as 3M Filtek Bulk Fill in Class V Caries Restoration, Suggests Study

India: Researchers have found in a new study that Predicta Bioactive Bulk and 3M Filtek Bulk Fill Posterior Restorative showed equivalent effectiveness for restoring class V caries in high-risk patients.

The randomized clinical trial, published in the Journal of Conservative Dentistry and Endodontics, compared the clinical performance of a bioactive composite resin with a conventional non-bioactive composite in individuals prone to frequent tooth decay.
Dr. Apeksha Rao and colleagues from the Department of Conservative Dentistry and Endodontics, Vokkaligara Sangha Dental College and Hospital, Bengaluru, designed the investigation to address a persistent challenge in restorative dentistry—recurrent caries at the tooth–restoration interface. Materials that can either resist demineralization or encourage remineralization may extend the life of restorations, but clinical evidence supporting such bioactive products has remained limited.
The researchers recruited 20 adult patients identified as high caries risk, each presenting with symmetrical class V lesions on the buccal surfaces of posterior teeth. Using a split-mouth design, one side of each patient’s mouth was restored with Predicta Bioactive Bulk composite (Parkell™), while the opposite side received the non-bioactive 3M™ Filtek™ Bulk Fill Posterior Restorative. This method ensured that each participant served as their own control, improving the reliability of comparisons.
The key findings of the study were as follows:
  • Follow-up assessments were carried out at 1, 3, 6, and 12 months.
  • The Fédération Dentaire Internationale (FDI) criteria were used to evaluate marginal adaptation, marginal staining, fracture, and retention, and recurrence of initial pathology.
  • Statistical analysis included the Chi-square test, the Cochran’s Q test, and the McNemar’s post-hoc test with a significance level of p < 0.05.
  • Both restorative materials showed similar performance at all time points.
  • No statistically significant differences were noted in marginal integrity, color stability, fracture resistance, or development of secondary caries.
  • Patients tolerated both materials well throughout the study.
  • Retention rates for both materials remained high over the 12 months.
The authors noted that while bioactive composites are engineered to release ions that may help neutralize acids and encourage remineralization, these theoretical advantages did not translate into measurable short-term clinical superiority over the conventional bulk-fill composite in this study. They emphasized that the trial’s relatively small sample size and limited follow-up period are important considerations. Longer-term monitoring of these patients is planned, and the team recommends larger studies with extended observation to determine whether differences might appear over time or in other types of carious lesions.
Despite these limitations, the findings provide valuable evidence for clinicians. Both Predicta Bioactive Bulk and 3M™ Filtek™ Bulk Fill Posterior Restorative can be considered reliable options for managing class V lesions in individuals at elevated risk for caries. By demonstrating comparable clinical outcomes, the study supports the continued use of either material based on factors such as practitioner preference, cost, and availability rather than expected differences in performance.
The research highlights that, at least within a one-year timeframe, the anticipated benefits of bioactive composites may not yield a clinical advantage in high-risk patients. Further investigations are needed to explore their potential in other clinical scenarios and over longer periods.
Reference:
Rao, Apeksha; Anithakumari, R.; Adarsha, M. S; Sudhanva, M. E; Vikram, R; Naveen Kumar, N. Clinical evaluation of bioactive composite resin in class V lesions in high-risk caries patients: A randomized split-mouth trial. Journal of Conservative Dentistry and Endodontics 28(9):p 905-910, September 2025. | DOI: 10.4103/JCDE.JCDE_157_25

Powered by WPeMatico